Kaoru Funabashi - Concepedia

Author

Kaoru Funabashi

Taiho Pharmaceutical (Japan)

Also Known As

K. Funabashi, Kaoru Funabashi

Publications

620

Citations

H-Index

Concepts

All Affiliations

Taiho Pharmaceutical (Japan)Harvard University Food Research Institute

About

Kaoru Funabashi is an author at Taiho Pharmaceutical (Japan) specializing in medicine, vascular biology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	218
2	Natural Sciences	1	1	54
3	Biochemistry	1	1	115
4	Cell Biology	1	1	54
5	Immunology	1	1	115

Kaoru Funabashi

Publications

611

Citations

H-Index

Page 1

	Year	Citations
Futibatinib Is a Novel Irreversible FGFR 1–4 Inhibitor That Shows Selective Antitumor Activity against FGFR-Deregulated Tumors Hiroshi Sootome, Hidenori Fujita, Kenjiro Ito, Cancer Research	2020	184
In Vitro Biological Profile of a Highly Potent Novel Endothelin (ET) Antagonist BQ-123 Selective for the ETA Receptor Masaki Ihara, Kiyofumi Ishikawa, Takahiro Fukuroda, Journal of Cardiovascular Pharmacology Molecular PharmacologyEta ReceptorBiochemistryMedicinePhysiology	1992	115
TAS6417/CLN-081 Is a Pan-Mutation–Selective EGFR Tyrosine Kinase Inhibitor with a Broad Spectrum of Preclinical Activity against Clinically Relevant <i>EGFR</i> Mutations Hibiki Udagawa, Shinichi Hasako, Akihiro Ohashi, Molecular Cancer Research	2019	70
Discovery of 3-Ethyl-4-(3-isopropyl-4-(4-(1-methyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-imidazol-1-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridin-1-yl)benzamide (TAS-116) as a Potent, Selective, and Orally Available HSP90 Inhibitor Takao Uno, Yuichi Kawai, Satoshi Yamashita, Journal of Medicinal Chemistry	2018	55
Structural Basis of Human p70 Ribosomal S6 Kinase-1 Regulation by Activation Loop Phosphorylation T. Sunami, Noel Byrne, Ronald E. Diehl, Journal of Biological Chemistry Crystal StructureActivation Loop PhosphorylationMolecular RegulationMolecular BiologyGlucose Homeostasis	2009	54
Two Endothelin Receptor Subtypes in Porcine Arteries M. Ihara, Toshihiko Saeki, Kaoru Funabashi, Journal of Cardiovascular Pharmacology Porcine ArteriesVascular DiseaseMolecular PhysiologyCardiovascular DiseaseMedicine	1991	49
Discovery of Futibatinib: The First Covalent FGFR Kinase Inhibitor in Clinical Use Satoru Ito, Sachie Otsuki, Hirokazu Ohsawa, ACS Medicinal Chemistry Letters	2023	31
Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations Isao Miyazaki, Igor Odintsov, Keiji Ishida, Nature Cancer	2023	30
TAS0728, A Covalent-binding, HER2-selective Kinase Inhibitor Shows Potent Antitumor Activity in Preclinical Models Hiroki Irie, Kimihiro Ito, Yayoi Fujioka, Molecular Cancer Therapeutics	2019	13
<scp>TAS2940</scp>, a novel <scp>brain‐penetrable pan‐ERBB</scp> inhibitor, for tumors with <i>HER2</i> and <i>EGFR</i> aberrations Kei Oguchi, Hikari Araki, Shingo Tsuji, Cancer Science	2022	10

Page 1